Brind.

Basecamp Collaborates with Google DeepMind on AI Therapeutics

1 report, 1 independent Updated Wed 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Basecamp Research, an AI therapeutics company with offices in London and Boston, announced collaborations with AI firms, including Google DeepMind. Basecamp Research is focused on building an 'Internet of biology' from the ground up to train massive models. This initiative aims to design therapeutics across multiple modalities.

From bioxconomy.com

Why it matters

Some supportBrind's analysis of the reports

The partnership seeks to address the lack of a comprehensive biological dataset, noting that existing public domain data is heavily biased. By building this 'Internet of biology,' Basecamp Research aims to create large models capable of designing new therapeutics, which is central to its business model.

From bioxconomy.com

Who's involved

  • BasecampAI therapeutics company with offices in London and Boston, building the 'Internet of biology'.
  • Google DeepMindArtificial intelligence company owned by Google, collaborating on advanced AI projects.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • Google DeepMindSpeculative

    Google DeepMind could see increased demand for its AI therapeutics research capabilities due to the partnership.

  • EdenSpeculative

    Eden might see increased demand for proprietary data needed to train Basecamp's scaled AI models.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped